Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Vorasidenib for Certain IDH-Mutant Gliomas: Is It Worth It?
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. After years with limited treatment options, experts hailed vorasidenib “a promising breakthrough,” “a paradigm…
English